RareCan: Anita Cooper, non-executive director
Rare-cancer research company RareCan has named Anita Cooper non-executive director. She brings to the company more than 30 years of diverse scientific and pharmaceutical experience, with stints at Simbec-Orion and Parexel.
Cooper said, “I see a huge opportunity to increase the potential for better patient outcomes, by connecting people diagnosed with rare cancers with passionate researchers and facilitating data exchange to enable, enhance and speed research to support diagnostic and therapeutic advances. I will work with the RareCan team to contribute to this important endeavor.”
